Rare diseases
Investigational molecules
Locations
Back to Ireland104 clinical trials in Galway, Ireland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Darolutamide with Standard Therapy for Patients with High-Risk Localized Prostate Cancer
IrelandStudy comparing iberdomide, daratumumab and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma
IrelandStudy on the Effectiveness and Safety of Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
IrelandStudy of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer
IrelandStudy on Enzalutamide and Drug Combination for High-Risk Localized Prostate Cancer Patients
IrelandStudy on the Effects of ARO-APOC3 for Adults with Familial Chylomicronemia Syndrome
IrelandStudy of Cisplatin, Carboplatin and Durvalumab Treatment for Patients with Intermediate and High-Risk Oropharyngeal Cancer
IrelandStudy of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation
IrelandStudy on Preventing Infections After Abdominal Surgery Using D-PLEX with Doxycycline Hyclate for Patients Undergoing Abdominal Surgery
IrelandStudy on Elinzanetant for Treating Hot Flashes in Women with or at High Risk for Hormone-Receptor Positive Breast Cancer
IrelandStudy of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
IrelandStudy on the Effectiveness of Modified Vaccinia Ankara Vaccine in Preventing Mpox Infection in Adults
IrelandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on multiple myeloma, lung cancer, and various forms of breast cancer. Research includes novel therapeutic combinations and targeted treatments for both early-stage and metastatic conditions.
Investigating new treatment approaches using advanced targeted therapies and immunotherapy combinations.
Advanced research into blood-related cancers, particularly chronic lymphocytic leukemia and lymphoma. Studies evaluate novel drug combinations and treatment duration optimization.
Focusing on personalized treatment approaches based on measurable residual disease monitoring.
Innovative studies addressing hypertension and cardiovascular health, including research on obesity-related cardiovascular conditions and new therapeutic approaches.
Exploring novel interventions for blood pressure control and atherosclerosis prevention.
Clinical investigations focusing on chronic skin conditions, particularly atopic dermatitis and hidradenitis suppurativa, testing new therapeutic options.
Evaluating advanced treatments for patients requiring systemic therapy.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
